熱門資訊> 正文
AC Immune根据杨森协议获得第二笔里程碑付款
2024-09-17 23:00
- AC Immune SA (NASDAQ:ACIU) announced that it will receive the second ReTain-related milestone payment of CHF 24.6 million under its agreement with Janssen Pharmaceuticals, a Johnson & Johnson company.
- With last December’s milestone payment, this brings the total milestone payments received for ACI-35.030 related to this trial to CHF 40 million.
- Source: Press Release
More on AC Immune
- AC Immune: Takeda Partnership Brings Funds To Drive Pipeline Forward
- AC Immune stock climbs 7% on FDA fast track status for Alzheimer's drug
- Seeking Alpha’s Quant Rating on AC Immune
- Historical earnings data for AC Immune
- Financial information for AC Immune
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
